Skip to content

Ayurvedic Management of Chittodwega (Generalised Anxiety Disorder)

Efficacy of Brahmi Vati and Manasmitra Vataka in Chittodwega (Generalised Anxiety Disorder) Randomised Double Blind Comparative Clinical Trial. - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/014711
Enrollment
40
Registered
2018-07-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- DSM V Criterion for Generalised Anxiety Disorder. Health Condition 2: F411- Generalized anxiety disorder

Interventions

Intervention1: Brahmi Vati: 500 mg thrice a day orally for 45 days Control Intervention1: Manasmitra Vataka: 500 mg thrice a day orally for 45 days

Sponsors

Dr Siddhi Gangadhar Khot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Individuals between the age group of 20 to 60 years fulfilling the diagnostic criteria of GAD (DSM V) 2. Either sex

Exclusion criteria

Exclusion criteria: 1. Laxana of Unmada (co-morbid psychiatric disorders) 2. Psychotropic drugs four weeks prior to study 3. Patients with substance abuse like alcohol etc. 4. Patients with significant depression (BDI >17) 5. The patients with any other medical complications (Hypertension, Diabetes Mellitus 6. Female patients who are pregnant and lactating

Design outcomes

Primary

MeasureTime frame
Hamilton Anxiety Rating Scale(HARS)Timepoint: on 0th,15th,30th,45th day of intervention

Secondary

MeasureTime frame
1.GAD7-Item scale (Spitzer et al 2006) 2.Beck Depression Inventory (BDI) 3.Epworth Sleepiness Scale (ESS) 4.Pittsburg sleep quality 5.WHO Quality of Life-BREF (WHOQOL-BREF) 6.Clinical Global Impressions(CGI) Timepoint: on 0th,15th,30th,45th day of intervention

Countries

India

Contacts

Public ContactDr Siddhi Gangadhar Khot

KAHERS Shri B M K Ayurveda Mahavidyalaya Shahapur Belgaum

ayurbasavaraj@gmail.com9448634660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026